Novel motif:20
From FANTOM5_SSTAR
name: | motif20_TGNAGC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0007522 | visceral muscle development | 2.217658e-13 |
GO:0051293 | establishment of spindle localization | 2.222387e-10 |
GO:0006821 | chloride transport | 3.427042e-10 |
GO:0010984 | regulation of lipoprotein particle clearance | 6.976882e-10 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 9.283898e-10 |
GO:0015698 | inorganic anion transport | 4.779103e-9 |
GO:0009303 | rRNA transcription | 5.166038e-9 |
GO:0000132 | establishment of mitotic spindle orientation | 1.028727e-8 |
GO:0007288 | sperm axoneme assembly | 5.231357e-8 |
GO:0007509 | mesoderm migration involved in gastrulation | 6.524924e-8 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 1.040160e-7 |
GO:0040001 | establishment of mitotic spindle localization | 1.580599e-7 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 2.123437e-7 |
GO:0008078 | mesodermal cell migration | 2.191570e-7 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 3.602981e-7 |
GO:0030010 | establishment of cell polarity | 5.516614e-7 |
GO:0051298 | centrosome duplication | 5.671503e-7 |
GO:0046314 | phosphocreatine biosynthetic process | 9.156936e-7 |
GO:0043171 | peptide catabolic process | 1.240731e-6 |
GO:0042396 | phosphagen biosynthetic process | 1.393668e-6 |
GO:0032796 | uropod organization | 1.655236e-6 |
GO:0090224 | regulation of spindle organization | 1.794273e-6 |
GO:0031333 | negative regulation of protein complex assembly | 1.983469e-6 |
GO:0006820 | anion transport | 2.516200e-6 |
GO:0060346 | bone trabecula formation | 2.786524e-6 |
GO:0035082 | axoneme assembly | 3.346192e-6 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 3.377828e-6 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 3.645765e-6 |
GO:0010897 | negative regulation of triglyceride catabolic process | 3.645765e-6 |
GO:0045218 | zonula adherens maintenance | 4.048869e-6 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 5.080215e-6 |
GO:0030837 | negative regulation of actin filament polymerization | 5.220233e-6 |
GO:0003230 | cardiac atrium development | 5.410961e-6 |
GO:0002002 | regulation of angiotensin levels in blood | 5.826168e-6 |
GO:0043462 | regulation of ATPase activity | 6.236479e-6 |
GO:0090136 | epithelial cell-cell adhesion | 6.392828e-6 |
GO:0001574 | ganglioside biosynthetic process | 6.475645e-6 |
GO:0006853 | carnitine shuttle | 6.668381e-6 |
GO:0009304 | tRNA transcription | 6.836778e-6 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 8.511274e-6 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 8.733303e-6 |
GO:0003209 | cardiac atrium morphogenesis | 9.462729e-6 |
GO:0051591 | response to cAMP | 1.003245e-5 |
GO:0001768 | establishment of T cell polarity | 1.035389e-5 |
GO:0001661 | conditioned taste aversion | 1.035532e-5 |
GO:0006884 | cell volume homeostasis | 1.075088e-5 |
GO:0021554 | optic nerve development | 1.295315e-5 |
GO:0007398 | ectoderm development | 1.585554e-5 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 1.834582e-5 |
GO:0010388 | cullin deneddylation | 2.013486e-5 |
GO:0006600 | creatine metabolic process | 2.525979e-5 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 2.547548e-5 |
GO:0042304 | regulation of fatty acid biosynthetic process | 2.568129e-5 |
GO:0085029 | extracellular matrix assembly | 2.720214e-5 |
GO:0070943 | neutrophil mediated killing of symbiont cell | 2.760759e-5 |
GO:0010896 | regulation of triglyceride catabolic process | 2.900030e-5 |
GO:0048251 | elastic fiber assembly | 3.065490e-5 |
GO:0060337 | type I interferon-mediated signaling pathway | 3.129624e-5 |
GO:0045933 | positive regulation of muscle contraction | 3.322391e-5 |
GO:0006740 | NADPH regeneration | 3.337762e-5 |
GO:0032272 | negative regulation of protein polymerization | 3.477288e-5 |
GO:0090140 | regulation of mitochondrial fission | 4.280339e-5 |
GO:0051546 | keratinocyte migration | 4.356564e-5 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 4.380820e-5 |
GO:0032571 | response to vitamin K | 4.507905e-5 |
GO:0007163 | establishment or maintenance of cell polarity | 5.296041e-5 |
GO:0000212 | meiotic spindle organization | 5.335676e-5 |
GO:0006384 | transcription initiation from RNA polymerase III promoter | 5.551395e-5 |
GO:0010815 | bradykinin catabolic process | 5.629881e-5 |
GO:0042733 | embryonic digit morphogenesis | 5.714405e-5 |
GO:0035601 | protein deacylation | 5.888660e-5 |
GO:0006476 | protein deacetylation | 6.253463e-5 |
GO:0015858 | nucleoside transport | 6.298028e-5 |
GO:0070933 | histone H4 deacetylation | 6.691678e-5 |
GO:0090102 | cochlea development | 6.811570e-5 |
GO:0034340 | response to type I interferon | 6.962962e-5 |
GO:2000171 | negative regulation of dendrite development | 7.239058e-5 |
GO:0008210 | estrogen metabolic process | 7.248196e-5 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 7.287692e-5 |
GO:0035814 | negative regulation of renal sodium excretion | 7.432434e-5 |
GO:0021562 | vestibulocochlear nerve development | 7.519241e-5 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 7.896674e-5 |
GO:0021631 | optic nerve morphogenesis | 8.492207e-5 |
GO:0071585 | detoxification of cadmium ion | 8.723849e-5 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 8.858458e-5 |
GO:0016575 | histone deacetylation | 8.895447e-5 |
GO:0072162 | metanephric mesenchymal cell differentiation | 8.996213e-5 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 9.719035e-5 |
GO:0030835 | negative regulation of actin filament depolymerization | 9.782061e-5 |
GO:0071732 | cellular response to nitric oxide | 1.009741e-4 |
GO:0051693 | actin filament capping | 1.056122e-4 |
GO:0034969 | histone arginine methylation | 1.133277e-4 |
GO:0060644 | mammary gland epithelial cell differentiation | 1.155552e-4 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 1.194311e-4 |
GO:0034330 | cell junction organization | 1.196409e-4 |
GO:0019693 | ribose phosphate metabolic process | 1.271754e-4 |
GO:0035067 | negative regulation of histone acetylation | 1.275324e-4 |
GO:0071584 | negative regulation of zinc ion import | 1.417975e-4 |
GO:0090281 | negative regulation of calcium ion import | 1.417975e-4 |
GO:0071731 | response to nitric oxide | 1.434445e-4 |
GO:0018345 | protein palmitoylation | 1.475361e-4 |
GO:0009109 | coenzyme catabolic process | 1.478551e-4 |
GO:0072277 | metanephric glomerular capillary formation | 1.630230e-4 |
GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 1.695315e-4 |
GO:0021819 | layer formation in cerebral cortex | 1.845615e-4 |
GO:0060977 | coronary vasculature morphogenesis | 1.860216e-4 |
GO:0048711 | positive regulation of astrocyte differentiation | 1.971436e-4 |
GO:0006099 | tricarboxylic acid cycle | 1.972600e-4 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 1.981626e-4 |
GO:0035089 | establishment of apical/basal cell polarity | 2.007855e-4 |
GO:0006098 | pentose-phosphate shunt | 2.008705e-4 |
GO:0033590 | response to cobalamin | 2.053697e-4 |
GO:0006117 | acetaldehyde metabolic process | 2.053697e-4 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 2.127182e-4 |
GO:0035909 | aorta morphogenesis | 2.181893e-4 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 2.186140e-4 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 2.186140e-4 |
GO:0018200 | peptidyl-glutamic acid modification | 2.188394e-4 |
GO:0051295 | establishment of meiotic spindle localization | 2.237181e-4 |
GO:0046487 | glyoxylate metabolic process | 2.415379e-4 |
GO:0019320 | hexose catabolic process | 2.431321e-4 |
GO:0060253 | negative regulation of glial cell proliferation | 2.680873e-4 |
GO:0070932 | histone H3 deacetylation | 2.739880e-4 |
GO:0045687 | positive regulation of glial cell differentiation | 2.881286e-4 |
GO:0018022 | peptidyl-lysine methylation | 2.954670e-4 |
GO:0002026 | regulation of the force of heart contraction | 2.957913e-4 |
GO:0006471 | protein ADP-ribosylation | 3.005109e-4 |
GO:0045217 | cell-cell junction maintenance | 3.062420e-4 |
GO:0048841 | regulation of axon extension involved in axon guidance | 3.063154e-4 |
GO:0006007 | glucose catabolic process | 3.066761e-4 |
GO:0046356 | acetyl-CoA catabolic process | 3.101315e-4 |
GO:0007132 | meiotic metaphase I | 3.145729e-4 |
GO:0090169 | regulation of spindle assembly | 3.155652e-4 |
GO:0090234 | regulation of kinetochore assembly | 3.155652e-4 |
GO:0019532 | oxalate transport | 3.245619e-4 |
GO:0060191 | regulation of lipase activity | 3.447850e-4 |
GO:0043299 | leukocyte degranulation | 3.560468e-4 |
GO:0051323 | metaphase | 3.592927e-4 |
GO:0046164 | alcohol catabolic process | 3.595936e-4 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 3.675058e-4 |
GO:0045955 | negative regulation of calcium ion-dependent exocytosis | 3.677396e-4 |
GO:0001573 | ganglioside metabolic process | 3.808656e-4 |
GO:0060192 | negative regulation of lipase activity | 4.121539e-4 |
GO:0051660 | establishment of centrosome localization | 4.340102e-4 |
GO:0021540 | corpus callosum morphogenesis | 4.340102e-4 |
GO:0006760 | folic acid-containing compound metabolic process | 4.369167e-4 |
GO:0046365 | monosaccharide catabolic process | 4.439524e-4 |
GO:0071956 | cellular component maintenance at cellular level | 4.461276e-4 |
GO:0006110 | regulation of glycolysis | 4.603538e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 4.765148e-4 |
GO:0000226 | microtubule cytoskeleton organization | 4.992560e-4 |
GO:0019321 | pentose metabolic process | 5.050765e-4 |
GO:0009060 | aerobic respiration | 5.198540e-4 |
GO:0034505 | tooth mineralization | 5.205097e-4 |
GO:2000974 | negative regulation of pro-B cell differentiation | 5.221184e-4 |
GO:0002906 | negative regulation of mature B cell apoptosis | 5.221184e-4 |
GO:0021801 | cerebral cortex radial glia guided migration | 5.306691e-4 |
GO:0061054 | dermatome development | 5.410696e-4 |
GO:0051835 | positive regulation of synapse structural plasticity | 5.410696e-4 |
GO:0043163 | cell envelope organization | 5.410696e-4 |
GO:0051645 | Golgi localization | 5.410696e-4 |
GO:0031658 | negative regulation of cyclin-dependent protein kinase activity involved in G1/S | 5.543001e-4 |
GO:0007092 | activation of mitotic anaphase-promoting complex activity | 5.543001e-4 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 5.679457e-4 |
GO:0097107 | postsynaptic density assembly | 5.679457e-4 |
GO:0034766 | negative regulation of ion transmembrane transport | 5.679457e-4 |
GO:0072164 | mesonephric tubule development | 5.790250e-4 |
GO:0030237 | female sex determination | 6.223818e-4 |
GO:0010455 | positive regulation of cell fate commitment | 6.346458e-4 |
GO:0043985 | histone H4-R3 methylation | 6.379263e-4 |
GO:0090209 | negative regulation of triglyceride metabolic process | 6.619544e-4 |
GO:0060976 | coronary vasculature development | 6.798421e-4 |
GO:0090141 | positive regulation of mitochondrial fission | 6.829059e-4 |
GO:0031936 | negative regulation of chromatin silencing | 7.119273e-4 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 7.122353e-4 |
GO:0048627 | myoblast development | 7.151931e-4 |
GO:0001578 | microtubule bundle formation | 7.252416e-4 |
GO:0070509 | calcium ion import | 7.352796e-4 |
GO:0042447 | hormone catabolic process | 7.368332e-4 |
GO:0007051 | spindle organization | 7.441548e-4 |
GO:0007016 | cytoskeletal anchoring at plasma membrane | 7.477673e-4 |
GO:0018095 | protein polyglutamylation | 7.560660e-4 |
GO:2000786 | positive regulation of autophagic vacuole assembly | 7.728647e-4 |
GO:0030488 | tRNA methylation | 7.728647e-4 |
GO:0051494 | negative regulation of cytoskeleton organization | 7.945936e-4 |
GO:0014015 | positive regulation of gliogenesis | 8.077092e-4 |
GO:0010517 | regulation of phospholipase activity | 8.087009e-4 |
GO:0071280 | cellular response to copper ion | 8.256340e-4 |
GO:0016241 | regulation of macroautophagy | 8.256340e-4 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 8.467577e-4 |
GO:0042483 | negative regulation of odontogenesis | 8.509266e-4 |
GO:0000302 | response to reactive oxygen species | 8.653406e-4 |
GO:0010536 | positive regulation of activation of Janus kinase activity | 8.741305e-4 |
GO:0090162 | establishment of epithelial cell polarity | 8.788862e-4 |
GO:0032862 | activation of Rho GTPase activity | 8.907687e-4 |
GO:0014040 | positive regulation of Schwann cell differentiation | 9.222215e-4 |
GO:0035105 | sterol regulatory element binding protein import into nucleus | 9.307784e-4 |
GO:0070947 | neutrophil mediated killing of fungus | 9.320833e-4 |
GO:0006684 | sphingomyelin metabolic process | 9.596182e-4 |
GO:0032365 | intracellular lipid transport | 9.664310e-4 |
GO:0090130 | tissue migration | 9.702405e-4 |
GO:0051187 | cofactor catabolic process | 9.834193e-4 |
GO:0045061 | thymic T cell selection | 9.953545e-4 |
GO:0072668 | tubulin complex biogenesis | 1.012363e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 1.051417e-3 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 1.052834e-3 |
GO:0070734 | histone H3-K27 methylation | 1.066626e-3 |
GO:0090149 | membrane fission involved in mitochondrial fission | 1.095922e-3 |
GO:0003374 | dynamin polymerization involved in mitochondrial fission | 1.095922e-3 |
GO:0072239 | metanephric glomerulus vasculature development | 1.098806e-3 |
GO:0006739 | NADP metabolic process | 1.140161e-3 |
GO:0033326 | cerebrospinal fluid secretion | 1.163971e-3 |
GO:0014807 | regulation of somitogenesis | 1.176918e-3 |
GO:0005997 | xylulose metabolic process | 1.176918e-3 |
GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development | 1.191310e-3 |
GO:0007202 | activation of phospholipase C activity | 1.224069e-3 |
GO:0030953 | astral microtubule organization | 1.231792e-3 |
GO:0030834 | regulation of actin filament depolymerization | 1.232186e-3 |
GO:0001885 | endothelial cell development | 1.246971e-3 |
GO:0042472 | inner ear morphogenesis | 1.302119e-3 |
GO:0001553 | luteinization | 1.302628e-3 |
GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 1.309151e-3 |
GO:0007512 | adult heart development | 1.336396e-3 |
GO:0090342 | regulation of cell aging | 1.366542e-3 |
GO:0034983 | peptidyl-lysine deacetylation | 1.376327e-3 |
GO:0035313 | wound healing, spreading of epidermal cells | 1.407313e-3 |
GO:0051081 | nuclear envelope disassembly | 1.409782e-3 |
GO:0045794 | negative regulation of cell volume | 1.420792e-3 |
GO:0006551 | leucine metabolic process | 1.441903e-3 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 1.507182e-3 |
GO:0061032 | visceral serous pericardium development | 1.507182e-3 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 1.555412e-3 |
GO:0060236 | regulation of mitotic spindle organization | 1.607471e-3 |
GO:0002830 | positive regulation of type 2 immune response | 1.659691e-3 |
GO:0031343 | positive regulation of cell killing | 1.683129e-3 |
GO:0010821 | regulation of mitochondrion organization | 1.711272e-3 |
GO:0045989 | positive regulation of striated muscle contraction | 1.732521e-3 |
GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 1.738253e-3 |
GO:0090307 | spindle assembly involved in mitosis | 1.792903e-3 |
GO:0060290 | transdifferentiation | 1.792903e-3 |
GO:0046884 | follicle-stimulating hormone secretion | 1.818829e-3 |
GO:0032275 | luteinizing hormone secretion | 1.818829e-3 |
GO:0046373 | L-arabinose metabolic process | 1.943042e-3 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 1.951426e-3 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 1.957868e-3 |
GO:0002523 | leukocyte migration involved in inflammatory response | 2.011853e-3 |
GO:0060343 | trabecula formation | 2.013431e-3 |
GO:0043244 | regulation of protein complex disassembly | 2.031720e-3 |
GO:0007000 | nucleolus organization | 2.037051e-3 |
GO:0031064 | negative regulation of histone deacetylation | 2.091493e-3 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 2.110499e-3 |
GO:0046173 | polyol biosynthetic process | 2.120099e-3 |
GO:0032613 | interleukin-10 production | 2.120099e-3 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 2.128222e-3 |
GO:0045060 | negative thymic T cell selection | 2.173172e-3 |
GO:0035269 | protein O-linked mannosylation | 2.249901e-3 |
GO:0071300 | cellular response to retinoic acid | 2.251670e-3 |
GO:0006081 | cellular aldehyde metabolic process | 2.276173e-3 |
GO:0060363 | cranial suture morphogenesis | 2.283816e-3 |
GO:0015840 | urea transport | 2.306761e-3 |
GO:0060923 | cardiac muscle cell fate commitment | 2.324912e-3 |
GO:0032463 | negative regulation of protein homooligomerization | 2.366868e-3 |
GO:0048839 | inner ear development | 2.385065e-3 |
GO:0003416 | endochondral bone growth | 2.386579e-3 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 2.407302e-3 |
GO:0060262 | negative regulation of N-terminal protein palmitoylation | 2.436733e-3 |
GO:0090241 | negative regulation of histone H4 acetylation | 2.463886e-3 |
GO:0071392 | cellular response to estradiol stimulus | 2.467249e-3 |
GO:0006105 | succinate metabolic process | 2.477895e-3 |
GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway | 2.501004e-3 |
GO:0034637 | cellular carbohydrate biosynthetic process | 2.530218e-3 |
GO:0044088 | regulation of vacuole organization | 2.564154e-3 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 2.580089e-3 |
GO:0097152 | mesenchymal cell apoptosis | 2.580089e-3 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 2.580089e-3 |
GO:0060982 | coronary artery morphogenesis | 2.580089e-3 |
GO:0042335 | cuticle development | 2.580089e-3 |
GO:0018027 | peptidyl-lysine dimethylation | 2.625623e-3 |
GO:0021602 | cranial nerve morphogenesis | 2.691666e-3 |
GO:0042471 | ear morphogenesis | 2.710441e-3 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 2.716154e-3 |
GO:0050902 | leukocyte adhesive activation | 2.716154e-3 |
GO:0003166 | bundle of His development | 2.741032e-3 |
GO:0070574 | cadmium ion transmembrane transport | 2.749051e-3 |
GO:0045606 | positive regulation of epidermal cell differentiation | 2.799274e-3 |
GO:0046165 | alcohol biosynthetic process | 2.838855e-3 |
GO:0060969 | negative regulation of gene silencing | 2.879028e-3 |
GO:0048842 | positive regulation of axon extension involved in axon guidance | 2.883961e-3 |
GO:0010518 | positive regulation of phospholipase activity | 2.948271e-3 |
GO:0000086 | G2/M transition of mitotic cell cycle | 2.964113e-3 |
GO:0045684 | positive regulation of epidermis development | 2.989546e-3 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 3.001766e-3 |
GO:0006306 | DNA methylation | 3.013807e-3 |
GO:0018026 | peptidyl-lysine monomethylation | 3.043505e-3 |
GO:0007021 | tubulin complex assembly | 3.053743e-3 |
GO:0045446 | endothelial cell differentiation | 3.101739e-3 |
GO:0044319 | wound healing, spreading of cells | 3.157898e-3 |
GO:0019883 | antigen processing and presentation of endogenous antigen | 3.161179e-3 |
GO:0048227 | plasma membrane to endosome transport | 3.164424e-3 |
GO:0048664 | neuron fate determination | 3.180729e-3 |
GO:0048705 | skeletal system morphogenesis | 3.181518e-3 |
GO:0045987 | positive regulation of smooth muscle contraction | 3.209434e-3 |
GO:0043001 | Golgi to plasma membrane protein transport | 3.286744e-3 |
GO:0060452 | positive regulation of cardiac muscle contraction | 3.381186e-3 |
GO:0072166 | posterior mesonephric tubule development | 3.395756e-3 |
GO:0042074 | cell migration involved in gastrulation | 3.447648e-3 |
GO:0010863 | positive regulation of phospholipase C activity | 3.475812e-3 |
GO:0015879 | carnitine transport | 3.480077e-3 |
GO:0031935 | regulation of chromatin silencing | 3.502322e-3 |
GO:0034111 | negative regulation of homotypic cell-cell adhesion | 3.566919e-3 |
GO:0060981 | cell migration involved in coronary angiogenesis | 3.567699e-3 |
GO:0071670 | smooth muscle cell chemotaxis | 3.567699e-3 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 3.588686e-3 |
GO:0033559 | unsaturated fatty acid metabolic process | 3.596049e-3 |
GO:0060251 | regulation of glial cell proliferation | 3.613854e-3 |
GO:0060193 | positive regulation of lipase activity | 3.637283e-3 |
GO:0060712 | spongiotrophoblast layer development | 3.646729e-3 |
GO:0010544 | negative regulation of platelet activation | 3.683988e-3 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 3.718633e-3 |
GO:0042756 | drinking behavior | 3.734492e-3 |
GO:0006633 | fatty acid biosynthetic process | 3.807202e-3 |
GO:0006094 | gluconeogenesis | 3.810582e-3 |
GO:0021799 | cerebral cortex radially oriented cell migration | 3.811623e-3 |
GO:0006497 | protein lipidation | 3.816897e-3 |
GO:2000737 | negative regulation of stem cell differentiation | 3.856264e-3 |
GO:0060348 | bone development | 3.871059e-3 |
GO:0045023 | G0 to G1 transition | 3.907030e-3 |
GO:0002005 | angiotensin catabolic process in blood | 3.907030e-3 |
GO:0045879 | negative regulation of smoothened signaling pathway | 3.949854e-3 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 3.956912e-3 |
GO:0045922 | negative regulation of fatty acid metabolic process | 3.962738e-3 |
GO:0050769 | positive regulation of neurogenesis | 3.981727e-3 |
GO:0048672 | positive regulation of collateral sprouting | 4.059552e-3 |
GO:0048680 | positive regulation of axon regeneration | 4.059552e-3 |
GO:0002579 | positive regulation of antigen processing and presentation | 4.078231e-3 |
GO:0007098 | centrosome cycle | 4.089418e-3 |
GO:0033238 | regulation of cellular amine metabolic process | 4.176066e-3 |
GO:0002635 | negative regulation of germinal center formation | 4.201701e-3 |
GO:0035802 | adrenal cortex formation | 4.223447e-3 |
GO:0001510 | RNA methylation | 4.233258e-3 |
GO:0031284 | positive regulation of guanylate cyclase activity | 4.243127e-3 |
GO:0071674 | mononuclear cell migration | 4.243127e-3 |
GO:0045645 | positive regulation of eosinophil differentiation | 4.283928e-3 |
GO:0045234 | protein palmitoleylation | 4.283928e-3 |
GO:0006948 | induction by virus of host cell-cell fusion | 4.283928e-3 |
GO:0007321 | sperm displacement | 4.283928e-3 |
GO:0031591 | wybutosine biosynthetic process | 4.283928e-3 |
GO:0060579 | ventral spinal cord interneuron fate commitment | 4.292439e-3 |
GO:0050703 | interleukin-1 alpha secretion | 4.346014e-3 |
GO:0070946 | neutrophil mediated killing of gram-positive bacterium | 4.346014e-3 |
GO:0090344 | negative regulation of cell aging | 4.442666e-3 |
GO:0007010 | cytoskeleton organization | 4.511547e-3 |
GO:0006449 | regulation of translational termination | 4.577700e-3 |
GO:0061031 | endodermal digestive tract morphogenesis | 4.640870e-3 |
GO:0051299 | centrosome separation | 4.685876e-3 |
GO:0006552 | leucine catabolic process | 4.685876e-3 |
GO:0006304 | DNA modification | 4.761392e-3 |
GO:0030198 | extracellular matrix organization | 4.834226e-3 |
GO:0046724 | oxalic acid secretion | 4.868935e-3 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 4.868935e-3 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 4.868935e-3 |
GO:0060349 | bone morphogenesis | 4.899299e-3 |
GO:0015864 | pyrimidine nucleoside transport | 4.922161e-3 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 4.925861e-3 |
GO:0034329 | cell junction assembly | 4.958154e-3 |
GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process | 4.964624e-3 |
GO:0021514 | ventral spinal cord interneuron differentiation | 4.970470e-3 |
GO:0097150 | neuronal stem cell maintenance | 4.981121e-3 |
GO:0032863 | activation of Rac GTPase activity | 4.981121e-3 |
GO:0048663 | neuron fate commitment | 4.998866e-3 |
GO:0060367 | sagittal suture morphogenesis | 5.001153e-3 |
GO:0060873 | anterior semicircular canal development | 5.001153e-3 |
GO:0070242 | thymocyte apoptosis | 5.001153e-3 |
GO:0060366 | lambdoid suture morphogenesis | 5.001153e-3 |
GO:0060875 | lateral semicircular canal development | 5.001153e-3 |
GO:0034959 | endothelin maturation | 5.001153e-3 |
GO:0010816 | calcitonin catabolic process | 5.001153e-3 |
GO:0010814 | substance P catabolic process | 5.001153e-3 |
GO:0022018 | lateral ganglionic eminence cell proliferation | 5.001153e-3 |
GO:0010626 | negative regulation of Schwann cell proliferation | 5.015604e-3 |
GO:0060732 | positive regulation of inositol phosphate biosynthetic process | 5.042491e-3 |
GO:0061034 | olfactory bulb mitral cell layer development | 5.042743e-3 |
GO:0007412 | axon target recognition | 5.071394e-3 |
GO:0007595 | lactation | 5.111472e-3 |
GO:0061298 | retina vasculature development in camera-type eye | 5.145101e-3 |
GO:0006688 | glycosphingolipid biosynthetic process | 5.183954e-3 |
GO:0046364 | monosaccharide biosynthetic process | 5.221961e-3 |
GO:0070989 | oxidative demethylation | 5.297555e-3 |
GO:0032856 | activation of Ras GTPase activity | 5.349909e-3 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 5.372843e-3 |
GO:0071299 | cellular response to vitamin A | 5.377722e-3 |
GO:0001973 | adenosine receptor signaling pathway | 5.415218e-3 |
GO:0019322 | pentose biosynthetic process | 5.453460e-3 |
GO:0043242 | negative regulation of protein complex disassembly | 5.460643e-3 |
GO:0006107 | oxaloacetate metabolic process | 5.480118e-3 |
GO:0003180 | aortic valve morphogenesis | 5.506797e-3 |
GO:0061360 | optic chiasma development | 5.535240e-3 |
GO:0035799 | ureter maturation | 5.535240e-3 |
GO:2000597 | positive regulation of optic nerve formation | 5.535240e-3 |
GO:0021650 | vestibulocochlear nerve formation | 5.535240e-3 |
GO:0006021 | inositol biosynthetic process | 5.535240e-3 |
GO:0021633 | optic nerve structural organization | 5.535240e-3 |
GO:0007586 | digestion | 5.571671e-3 |
GO:0046456 | icosanoid biosynthetic process | 5.630484e-3 |
GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 5.664313e-3 |
GO:0003158 | endothelium development | 5.685485e-3 |
GO:0060620 | regulation of cholesterol import | 5.788634e-3 |
GO:0019348 | dolichol metabolic process | 5.822707e-3 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 5.851234e-3 |
GO:0044275 | cellular carbohydrate catabolic process | 5.854231e-3 |
GO:0019369 | arachidonic acid metabolic process | 5.900765e-3 |
GO:0090103 | cochlea morphogenesis | 5.914104e-3 |
GO:0043303 | mast cell degranulation | 6.137658e-3 |
GO:0001738 | morphogenesis of a polarized epithelium | 6.175731e-3 |
GO:0048843 | negative regulation of axon extension involved in axon guidance | 6.205291e-3 |
GO:0010535 | positive regulation of activation of JAK2 kinase activity | 6.322169e-3 |
GO:0045604 | regulation of epidermal cell differentiation | 6.365312e-3 |
GO:2000369 | regulation of clathrin-mediated endocytosis | 6.368282e-3 |
GO:0001880 | Mullerian duct regression | 6.368282e-3 |
GO:0060708 | spongiotrophoblast differentiation | 6.383845e-3 |
GO:0060364 | frontal suture morphogenesis | 6.384615e-3 |
GO:0000022 | mitotic spindle elongation | 6.398854e-3 |
GO:0061383 | trabecula morphogenesis | 6.448767e-3 |
GO:0002077 | acrosome matrix dispersal | 6.512141e-3 |
GO:0030321 | transepithelial chloride transport | 6.566617e-3 |
GO:0007440 | foregut morphogenesis | 6.654117e-3 |
GO:0051066 | dihydrobiopterin metabolic process | 6.674815e-3 |
GO:0046390 | ribose phosphate biosynthetic process | 6.674815e-3 |
GO:0046339 | diacylglycerol metabolic process | 6.731820e-3 |
GO:0070527 | platelet aggregation | 6.735251e-3 |
GO:0060448 | dichotomous subdivision of terminal units involved in lung branching | 6.767225e-3 |
GO:0050432 | catecholamine secretion | 6.767225e-3 |
GO:0045198 | establishment of epithelial cell apical/basal polarity | 6.920177e-3 |
GO:0060621 | negative regulation of cholesterol import | 6.920177e-3 |
GO:0048521 | negative regulation of behavior | 6.996380e-3 |
GO:0002019 | regulation of renal output by angiotensin | 7.077866e-3 |
GO:0007501 | mesodermal cell fate specification | 7.116094e-3 |
GO:0009912 | auditory receptor cell fate commitment | 7.141024e-3 |
GO:0045662 | negative regulation of myoblast differentiation | 7.151465e-3 |
GO:0042737 | drug catabolic process | 7.168677e-3 |
GO:0021520 | spinal cord motor neuron cell fate specification | 7.222039e-3 |
GO:0006348 | chromatin silencing at telomere | 7.255562e-3 |
GO:0042631 | cellular response to water deprivation | 7.255562e-3 |
GO:0006784 | heme a biosynthetic process | 7.284290e-3 |
GO:0035545 | determination of left/right asymmetry in nervous system | 7.284290e-3 |
GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen | 7.284290e-3 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 7.284290e-3 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 7.428170e-3 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 7.428170e-3 |
GO:0015684 | ferrous iron transport | 7.428170e-3 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 7.428170e-3 |
GO:0005999 | xylulose biosynthetic process | 7.428170e-3 |
GO:0043583 | ear development | 7.670860e-3 |
GO:0051291 | protein heterooligomerization | 7.782245e-3 |
GO:0044236 | multicellular organismal metabolic process | 7.786280e-3 |
GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway | 7.791072e-3 |
GO:0002443 | leukocyte mediated immunity | 7.799119e-3 |
GO:0046434 | organophosphate catabolic process | 7.844556e-3 |
GO:0046185 | aldehyde catabolic process | 7.989948e-3 |
GO:0033128 | negative regulation of histone phosphorylation | 8.091311e-3 |
GO:0071526 | semaphorin-plexin signaling pathway | 8.158682e-3 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 8.187049e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 8.263721e-3 |
GO:0010832 | negative regulation of myotube differentiation | 8.288754e-3 |
GO:0046626 | regulation of insulin receptor signaling pathway | 8.386342e-3 |
GO:0051890 | regulation of cardioblast differentiation | 8.413798e-3 |
GO:0031529 | ruffle organization | 8.464587e-3 |
GO:0048855 | adenohypophysis morphogenesis | 8.469737e-3 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 8.469737e-3 |
GO:0021771 | lateral geniculate nucleus development | 8.469737e-3 |
GO:0018160 | peptidyl-pyrromethane cofactor linkage | 8.469737e-3 |
GO:0070489 | T cell aggregation | 8.562968e-3 |
GO:0006420 | arginyl-tRNA aminoacylation | 8.562968e-3 |
GO:0045820 | negative regulation of glycolysis | 8.588496e-3 |
GO:0006382 | adenosine to inosine editing | 8.624435e-3 |
GO:0090026 | positive regulation of monocyte chemotaxis | 8.651644e-3 |
GO:0060177 | regulation of angiotensin metabolic process | 8.651644e-3 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 8.651644e-3 |
GO:0014014 | negative regulation of gliogenesis | 8.781512e-3 |
GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 8.875204e-3 |
GO:0006690 | icosanoid metabolic process | 8.892469e-3 |
GO:0043383 | negative T cell selection | 8.985049e-3 |
GO:0018993 | somatic sex determination | 9.128671e-3 |
GO:0019319 | hexose biosynthetic process | 9.173897e-3 |
GO:0007224 | smoothened signaling pathway | 9.212485e-3 |
GO:0030195 | negative regulation of blood coagulation | 9.212727e-3 |
GO:0001909 | leukocyte mediated cytotoxicity | 9.221589e-3 |
GO:0071545 | inositol phosphate catabolic process | 9.236656e-3 |
GO:0031575 | mitotic cell cycle G1/S transition checkpoint | 9.369097e-3 |
GO:0001516 | prostaglandin biosynthetic process | 9.440864e-3 |
GO:0003300 | cardiac muscle hypertrophy | 9.454100e-3 |
GO:0002444 | myeloid leukocyte mediated immunity | 9.462760e-3 |
GO:0034063 | stress granule assembly | 9.528260e-3 |
GO:0043084 | penile erection | 9.540665e-3 |
GO:2000778 | positive regulation of interleukin-6 secretion | 9.561141e-3 |
GO:0045055 | regulated secretory pathway | 9.657304e-3 |
GO:0097084 | vascular smooth muscle cell development | 9.682835e-3 |
GO:0072075 | metanephric mesenchyme development | 9.740678e-3 |
GO:0090251 | protein localization involved in establishment of planar polarity | 9.769362e-3 |
GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development | 9.835225e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0034623 | cellular macromolecular complex disassembly | 3.672015e-9 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 1.878044e-8 |
GO:0055090 | acylglycerol homeostasis | 2.020598e-8 |
GO:0044241 | lipid digestion | 2.529679e-8 |
GO:0032984 | macromolecular complex disassembly | 3.369638e-8 |
GO:0030300 | regulation of intestinal cholesterol absorption | 7.375336e-8 |
GO:0006869 | lipid transport | 1.573791e-7 |
GO:0015914 | phospholipid transport | 1.666248e-7 |
GO:0033344 | cholesterol efflux | 2.612991e-7 |
GO:0019532 | oxalate transport | 4.178106e-7 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 7.455375e-7 |
GO:0071702 | organic substance transport | 8.860004e-7 |
GO:0046470 | phosphatidylcholine metabolic process | 1.133542e-6 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 1.515472e-6 |
GO:0060192 | negative regulation of lipase activity | 1.725090e-6 |
GO:0051937 | catecholamine transport | 1.860829e-6 |
GO:0055088 | lipid homeostasis | 1.861012e-6 |
GO:0033700 | phospholipid efflux | 1.861714e-6 |
GO:0010876 | lipid localization | 2.289184e-6 |
GO:0071845 | cellular component disassembly at cellular level | 3.216944e-6 |
GO:0060415 | muscle tissue morphogenesis | 4.256581e-6 |
GO:0003229 | ventricular cardiac muscle tissue development | 4.269464e-6 |
GO:0048747 | muscle fiber development | 4.547156e-6 |
GO:0044240 | multicellular organismal lipid catabolic process | 5.800033e-6 |
GO:0022411 | cellular component disassembly | 7.591388e-6 |
GO:0032374 | regulation of cholesterol transport | 8.032584e-6 |
GO:0065005 | protein-lipid complex assembly | 8.106917e-6 |
GO:0043624 | cellular protein complex disassembly | 8.637495e-6 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 9.826165e-6 |
GO:0007522 | visceral muscle development | 1.006524e-5 |
GO:0043691 | reverse cholesterol transport | 1.250836e-5 |
GO:0042439 | ethanolamine-containing compound metabolic process | 1.308878e-5 |
GO:0045924 | regulation of female receptivity | 2.715116e-5 |
GO:0055008 | cardiac muscle tissue morphogenesis | 2.828016e-5 |
GO:0032375 | negative regulation of cholesterol transport | 2.957481e-5 |
GO:0015844 | monoamine transport | 3.324451e-5 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 3.811351e-5 |
GO:0071071 | regulation of phospholipid biosynthetic process | 4.131960e-5 |
GO:0070286 | axonemal dynein complex assembly | 4.533859e-5 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 4.702624e-5 |
GO:0030301 | cholesterol transport | 5.015495e-5 |
GO:0030049 | muscle filament sliding | 5.267493e-5 |
GO:0045226 | extracellular polysaccharide biosynthetic process | 5.591204e-5 |
GO:0002077 | acrosome matrix dispersal | 5.591204e-5 |
GO:0042632 | cholesterol homeostasis | 6.158800e-5 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 6.605118e-5 |
GO:0043241 | protein complex disassembly | 7.200921e-5 |
GO:0007621 | negative regulation of female receptivity | 7.235356e-5 |
GO:0031329 | regulation of cellular catabolic process | 7.735168e-5 |
GO:0019987 | negative regulation of anti-apoptosis | 8.304796e-5 |
GO:0042178 | xenobiotic catabolic process | 9.317525e-5 |
GO:0006629 | lipid metabolic process | 9.487998e-5 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 9.984325e-5 |
GO:0010873 | positive regulation of cholesterol esterification | 1.090361e-4 |
GO:0072015 | glomerular visceral epithelial cell development | 1.125649e-4 |
GO:0000902 | cell morphogenesis | 1.205338e-4 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 1.249174e-4 |
GO:0002921 | negative regulation of humoral immune response | 1.265310e-4 |
GO:0048644 | muscle organ morphogenesis | 1.288197e-4 |
GO:0009894 | regulation of catabolic process | 1.313722e-4 |
GO:0030449 | regulation of complement activation | 1.440215e-4 |
GO:0007290 | spermatid nucleus elongation | 1.469941e-4 |
GO:0060711 | labyrinthine layer development | 1.528100e-4 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 1.639362e-4 |
GO:0033057 | multicellular organismal reproductive behavior | 1.773411e-4 |
GO:0045933 | positive regulation of muscle contraction | 1.813996e-4 |
GO:0006540 | glutamate decarboxylation to succinate | 1.817651e-4 |
GO:0017158 | regulation of calcium ion-dependent exocytosis | 2.006591e-4 |
GO:0050996 | positive regulation of lipid catabolic process | 2.139972e-4 |
GO:0032368 | regulation of lipid transport | 2.293042e-4 |
GO:0072284 | metanephric S-shaped body morphogenesis | 2.351123e-4 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 2.351123e-4 |
GO:0060137 | maternal process involved in parturition | 2.351123e-4 |
GO:0032571 | response to vitamin K | 2.376604e-4 |
GO:0032835 | glomerulus development | 2.403512e-4 |
GO:0042339 | keratan sulfate metabolic process | 2.416115e-4 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 2.416115e-4 |
GO:0006337 | nucleosome disassembly | 2.446441e-4 |
GO:0007008 | outer mitochondrial membrane organization | 2.449552e-4 |
GO:0045930 | negative regulation of mitotic cell cycle | 2.613679e-4 |
GO:0060180 | female mating behavior | 2.634853e-4 |
GO:0043314 | negative regulation of neutrophil degranulation | 2.636073e-4 |
GO:0006982 | response to lipid hydroperoxide | 2.636073e-4 |
GO:0070585 | protein localization in mitochondrion | 2.864924e-4 |
GO:0001570 | vasculogenesis | 2.938415e-4 |
GO:0000212 | meiotic spindle organization | 2.944419e-4 |
GO:0060621 | negative regulation of cholesterol import | 3.064954e-4 |
GO:0019637 | organophosphate metabolic process | 3.137891e-4 |
GO:0055091 | phospholipid homeostasis | 3.248526e-4 |
GO:0071827 | plasma lipoprotein particle organization | 3.464684e-4 |
GO:0015872 | dopamine transport | 3.707660e-4 |
GO:0034442 | regulation of lipoprotein oxidation | 3.798122e-4 |
GO:0015850 | organic alcohol transport | 3.887240e-4 |
GO:0006644 | phospholipid metabolic process | 3.916476e-4 |
GO:0010623 | developmental programmed cell death | 4.067190e-4 |
GO:0045618 | positive regulation of keratinocyte differentiation | 4.073840e-4 |
GO:0002358 | B cell homeostatic proliferation | 4.081382e-4 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 4.184929e-4 |
GO:0014819 | regulation of skeletal muscle contraction | 4.411715e-4 |
GO:0032696 | negative regulation of interleukin-13 production | 4.484102e-4 |
GO:0002027 | regulation of heart rate | 4.554118e-4 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 4.558029e-4 |
GO:0015881 | creatine transport | 4.558445e-4 |
GO:0031331 | positive regulation of cellular catabolic process | 4.593516e-4 |
GO:0045606 | positive regulation of epidermal cell differentiation | 4.680472e-4 |
GO:0010761 | fibroblast migration | 5.106611e-4 |
GO:0051004 | regulation of lipoprotein lipase activity | 5.109494e-4 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 5.454242e-4 |
GO:0030837 | negative regulation of actin filament polymerization | 5.867751e-4 |
GO:0032970 | regulation of actin filament-based process | 6.006135e-4 |
GO:0015908 | fatty acid transport | 6.159772e-4 |
GO:0003208 | cardiac ventricle morphogenesis | 6.359803e-4 |
GO:0070244 | negative regulation of thymocyte apoptosis | 6.384970e-4 |
GO:0021707 | cerebellar granule cell differentiation | 6.575316e-4 |
GO:0007258 | JUN phosphorylation | 6.575316e-4 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 6.765443e-4 |
GO:0046487 | glyoxylate metabolic process | 6.765443e-4 |
GO:0035441 | cell migration involved in vasculogenesis | 6.780990e-4 |
GO:0010872 | regulation of cholesterol esterification | 6.889709e-4 |
GO:0044255 | cellular lipid metabolic process | 6.928884e-4 |
GO:0070252 | actin-mediated cell contraction | 6.964774e-4 |
GO:0048739 | cardiac muscle fiber development | 6.964774e-4 |
GO:0003206 | cardiac chamber morphogenesis | 7.178628e-4 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 7.388349e-4 |
GO:0008217 | regulation of blood pressure | 7.856396e-4 |
GO:0032956 | regulation of actin cytoskeleton organization | 8.070816e-4 |
GO:0035725 | sodium ion transmembrane transport | 8.313470e-4 |
GO:0030299 | intestinal cholesterol absorption | 8.420352e-4 |
GO:0006471 | protein ADP-ribosylation | 8.585130e-4 |
GO:0032989 | cellular component morphogenesis | 8.741455e-4 |
GO:0050746 | regulation of lipoprotein metabolic process | 8.899633e-4 |
GO:0045989 | positive regulation of striated muscle contraction | 8.951241e-4 |
GO:0009098 | leucine biosynthetic process | 9.174441e-4 |
GO:0006550 | isoleucine catabolic process | 9.174441e-4 |
GO:0021575 | hindbrain morphogenesis | 9.246055e-4 |
GO:0072655 | establishment of protein localization in mitochondrion | 9.433881e-4 |
GO:0006656 | phosphatidylcholine biosynthetic process | 9.559356e-4 |
GO:0003338 | metanephros morphogenesis | 1.022578e-3 |
GO:0003205 | cardiac chamber development | 1.041779e-3 |
GO:0044106 | cellular amine metabolic process | 1.063761e-3 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 1.072130e-3 |
GO:0044058 | regulation of digestive system process | 1.074523e-3 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 1.111421e-3 |
GO:0019255 | glucose 1-phosphate metabolic process | 1.131487e-3 |
GO:0033275 | actin-myosin filament sliding | 1.147877e-3 |
GO:0050994 | regulation of lipid catabolic process | 1.150321e-3 |
GO:0050432 | catecholamine secretion | 1.167582e-3 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 1.179783e-3 |
GO:0048340 | paraxial mesoderm morphogenesis | 1.201547e-3 |
GO:0060712 | spongiotrophoblast layer development | 1.236112e-3 |
GO:0042448 | progesterone metabolic process | 1.285968e-3 |
GO:0008542 | visual learning | 1.309655e-3 |
GO:0048241 | epinephrine transport | 1.327224e-3 |
GO:0010896 | regulation of triglyceride catabolic process | 1.337529e-3 |
GO:0034369 | plasma lipoprotein particle remodeling | 1.339146e-3 |
GO:0002227 | innate immune response in mucosa | 1.344406e-3 |
GO:0010817 | regulation of hormone levels | 1.349900e-3 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 1.354561e-3 |
GO:0006549 | isoleucine metabolic process | 1.373423e-3 |
GO:0060716 | labyrinthine layer blood vessel development | 1.384971e-3 |
GO:0034380 | high-density lipoprotein particle assembly | 1.429446e-3 |
GO:0021683 | cerebellar granular layer morphogenesis | 1.498822e-3 |
GO:0031109 | microtubule polymerization or depolymerization | 1.498988e-3 |
GO:0002897 | positive regulation of central B cell tolerance induction | 1.593982e-3 |
GO:0002508 | central tolerance induction | 1.593982e-3 |
GO:0001777 | T cell homeostatic proliferation | 1.593982e-3 |
GO:0045578 | negative regulation of B cell differentiation | 1.602205e-3 |
GO:0032836 | glomerular basement membrane development | 1.602205e-3 |
GO:0072273 | metanephric nephron morphogenesis | 1.607572e-3 |
GO:0043313 | regulation of neutrophil degranulation | 1.626719e-3 |
GO:0009308 | amine metabolic process | 1.669574e-3 |
GO:0070328 | triglyceride homeostasis | 1.675280e-3 |
GO:0031427 | response to methotrexate | 1.675363e-3 |
GO:0021587 | cerebellum morphogenesis | 1.695491e-3 |
GO:0031398 | positive regulation of protein ubiquitination | 1.708878e-3 |
GO:0060066 | oviduct development | 1.746965e-3 |
GO:0060191 | regulation of lipase activity | 1.748315e-3 |
GO:0048741 | skeletal muscle fiber development | 1.756473e-3 |
GO:0034377 | plasma lipoprotein particle assembly | 1.808998e-3 |
GO:0072112 | glomerular visceral epithelial cell differentiation | 1.818677e-3 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 1.846455e-3 |
GO:0043988 | histone H3-S28 phosphorylation | 1.846455e-3 |
GO:0043987 | histone H3-S10 phosphorylation | 1.846455e-3 |
GO:0032929 | negative regulation of superoxide anion generation | 1.849255e-3 |
GO:0007140 | male meiosis | 1.878245e-3 |
GO:0032463 | negative regulation of protein homooligomerization | 1.904717e-3 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 1.906703e-3 |
GO:0030833 | regulation of actin filament polymerization | 1.939647e-3 |
GO:0006415 | translational termination | 1.984947e-3 |
GO:0003065 | positive regulation of heart rate by epinephrine | 2.000178e-3 |
GO:0051323 | metaphase | 2.000178e-3 |
GO:0016125 | sterol metabolic process | 2.006453e-3 |
GO:0061028 | establishment of endothelial barrier | 2.031270e-3 |
GO:0032048 | cardiolipin metabolic process | 2.035186e-3 |
GO:0003231 | cardiac ventricle development | 2.051207e-3 |
GO:0032233 | positive regulation of actin filament bundle assembly | 2.056704e-3 |
GO:0009395 | phospholipid catabolic process | 2.059273e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 2.207347e-3 |
GO:0051403 | stress-activated MAPK cascade | 2.207347e-3 |
GO:0006576 | cellular biogenic amine metabolic process | 2.305848e-3 |
GO:0097035 | regulation of membrane lipid distribution | 2.310255e-3 |
GO:0001970 | positive regulation of activation of membrane attack complex | 2.310255e-3 |
GO:0006140 | regulation of nucleotide metabolic process | 2.312333e-3 |
GO:0030728 | ovulation | 2.338117e-3 |
GO:0030046 | parallel actin filament bundle assembly | 2.351260e-3 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 2.380600e-3 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 2.413362e-3 |
GO:0016042 | lipid catabolic process | 2.418972e-3 |
GO:0014015 | positive regulation of gliogenesis | 2.439066e-3 |
GO:0006997 | nucleus organization | 2.471669e-3 |
GO:0014020 | primary neural tube formation | 2.474078e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 2.478166e-3 |
GO:0033194 | response to hydroperoxide | 2.538188e-3 |
GO:0051608 | histamine transport | 2.539948e-3 |
GO:0045022 | early endosome to late endosome transport | 2.584881e-3 |
GO:0090207 | regulation of triglyceride metabolic process | 2.596899e-3 |
GO:0015909 | long-chain fatty acid transport | 2.596899e-3 |
GO:0032714 | negative regulation of interleukin-5 production | 2.671591e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 2.682083e-3 |
GO:0070474 | positive regulation of uterine smooth muscle contraction | 2.851256e-3 |
GO:0030835 | negative regulation of actin filament depolymerization | 2.855434e-3 |
GO:0051261 | protein depolymerization | 2.911133e-3 |
GO:0042304 | regulation of fatty acid biosynthetic process | 2.945889e-3 |
GO:0048711 | positive regulation of astrocyte differentiation | 2.981004e-3 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.990412e-3 |
GO:0021546 | rhombomere development | 3.009997e-3 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 3.016786e-3 |
GO:0071354 | cellular response to interleukin-6 | 3.044945e-3 |
GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 3.074824e-3 |
GO:0043171 | peptide catabolic process | 3.081368e-3 |
GO:0007182 | common-partner SMAD protein phosphorylation | 3.081368e-3 |
GO:0001885 | endothelial cell development | 3.106359e-3 |
GO:0042490 | mechanoreceptor differentiation | 3.125280e-3 |
GO:0019233 | sensory perception of pain | 3.168265e-3 |
GO:0043587 | tongue morphogenesis | 3.231300e-3 |
GO:0000305 | response to oxygen radical | 3.292382e-3 |
GO:0032369 | negative regulation of lipid transport | 3.293614e-3 |
GO:0035659 | Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells | 3.307114e-3 |
GO:0014719 | satellite cell activation | 3.307114e-3 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 3.307114e-3 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 3.307458e-3 |
GO:0008272 | sulfate transport | 3.307458e-3 |
GO:0060620 | regulation of cholesterol import | 3.404258e-3 |
GO:0021612 | facial nerve structural organization | 3.408755e-3 |
GO:0045332 | phospholipid translocation | 3.408755e-3 |
GO:0045585 | positive regulation of cytotoxic T cell differentiation | 3.441060e-3 |
GO:0007274 | neuromuscular synaptic transmission | 3.458704e-3 |
GO:0048339 | paraxial mesoderm development | 3.469862e-3 |
GO:0035813 | regulation of renal sodium excretion | 3.471215e-3 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 3.496885e-3 |
GO:0043046 | DNA methylation involved in gamete generation | 3.570783e-3 |
GO:0070102 | interleukin-6-mediated signaling pathway | 3.673896e-3 |
GO:0008207 | C21-steroid hormone metabolic process | 3.674783e-3 |
GO:0032049 | cardiolipin biosynthetic process | 3.682507e-3 |
GO:0010977 | negative regulation of neuron projection development | 3.699344e-3 |
GO:0021978 | telencephalon regionalization | 3.723960e-3 |
GO:0033121 | regulation of purine nucleotide catabolic process | 3.818300e-3 |
GO:0032713 | negative regulation of interleukin-4 production | 3.818816e-3 |
GO:0032231 | regulation of actin filament bundle assembly | 3.838855e-3 |
GO:0008203 | cholesterol metabolic process | 3.856641e-3 |
GO:0002446 | neutrophil mediated immunity | 3.859539e-3 |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 3.964437e-3 |
GO:0008535 | respiratory chain complex IV assembly | 3.966481e-3 |
GO:0070233 | negative regulation of T cell apoptosis | 3.993219e-3 |
GO:0051583 | dopamine uptake | 4.065204e-3 |
GO:0051204 | protein insertion into mitochondrial membrane | 4.065204e-3 |
GO:0002331 | pre-B cell allelic exclusion | 4.065204e-3 |
GO:0051125 | regulation of actin nucleation | 4.136001e-3 |
GO:0017157 | regulation of exocytosis | 4.156455e-3 |
GO:0003007 | heart morphogenesis | 4.199866e-3 |
GO:0060674 | placenta blood vessel development | 4.207210e-3 |
GO:0014824 | artery smooth muscle contraction | 4.229578e-3 |
GO:0060290 | transdifferentiation | 4.266289e-3 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 4.266289e-3 |
GO:0021535 | cell migration in hindbrain | 4.301897e-3 |
GO:0006012 | galactose metabolic process | 4.441392e-3 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 4.446399e-3 |
GO:0050892 | intestinal absorption | 4.583802e-3 |
GO:0031333 | negative regulation of protein complex assembly | 4.642120e-3 |
GO:0043086 | negative regulation of catalytic activity | 4.646817e-3 |
GO:0003156 | regulation of organ formation | 4.672163e-3 |
GO:0031098 | stress-activated protein kinase signaling cascade | 4.708745e-3 |
GO:0042177 | negative regulation of protein catabolic process | 4.731279e-3 |
GO:0001969 | regulation of activation of membrane attack complex | 4.829409e-3 |
GO:0046544 | development of secondary male sexual characteristics | 4.831602e-3 |
GO:0006551 | leucine metabolic process | 4.877080e-3 |
GO:0090074 | negative regulation of protein homodimerization activity | 4.877080e-3 |
GO:0035265 | organ growth | 4.882017e-3 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 5.028129e-3 |
GO:0006546 | glycine catabolic process | 5.028129e-3 |
GO:0008064 | regulation of actin polymerization or depolymerization | 5.042297e-3 |
GO:0006941 | striated muscle contraction | 5.087163e-3 |
GO:0010815 | bradykinin catabolic process | 5.133926e-3 |
GO:0030317 | sperm motility | 5.235981e-3 |
GO:0042157 | lipoprotein metabolic process | 5.389342e-3 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 5.463585e-3 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 5.463585e-3 |
GO:0007356 | thorax and anterior abdomen determination | 5.463585e-3 |
GO:0051894 | positive regulation of focal adhesion assembly | 5.470055e-3 |
GO:0072109 | glomerular mesangium development | 5.494046e-3 |
GO:0032365 | intracellular lipid transport | 5.494046e-3 |
GO:0044062 | regulation of excretion | 5.502741e-3 |
GO:0021871 | forebrain regionalization | 5.528917e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 5.558056e-3 |
GO:0007440 | foregut morphogenesis | 5.800145e-3 |
GO:0001667 | ameboidal cell migration | 5.868196e-3 |
GO:0021569 | rhombomere 3 development | 5.880636e-3 |
GO:0060286 | flagellar cell motility | 5.924287e-3 |
GO:2000079 | regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 5.924287e-3 |
GO:0018343 | protein farnesylation | 5.924287e-3 |
GO:0015891 | siderophore transport | 5.924287e-3 |
GO:0002635 | negative regulation of germinal center formation | 5.924287e-3 |
GO:0043029 | T cell homeostasis | 5.934346e-3 |
GO:0060923 | cardiac muscle cell fate commitment | 6.052813e-3 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 6.052813e-3 |
GO:0070212 | protein poly-ADP-ribosylation | 6.066247e-3 |
GO:0032212 | positive regulation of telomere maintenance via telomerase | 6.066247e-3 |
GO:0031296 | B cell costimulation | 6.066247e-3 |
GO:0032787 | monocarboxylic acid metabolic process | 6.133645e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 6.167252e-3 |
GO:0018105 | peptidyl-serine phosphorylation | 6.206077e-3 |
GO:0014034 | neural crest cell fate commitment | 6.221289e-3 |
GO:0006705 | mineralocorticoid biosynthetic process | 6.221289e-3 |
GO:0032862 | activation of Rho GTPase activity | 6.300621e-3 |
GO:0001709 | cell fate determination | 6.372335e-3 |
GO:0007517 | muscle organ development | 6.469235e-3 |
GO:0009912 | auditory receptor cell fate commitment | 6.486048e-3 |
GO:0051129 | negative regulation of cellular component organization | 6.562169e-3 |
GO:0031581 | hemidesmosome assembly | 6.568210e-3 |
GO:0072668 | tubulin complex biogenesis | 6.634698e-3 |
GO:0048144 | fibroblast proliferation | 6.713969e-3 |
GO:0001845 | phagolysosome assembly | 6.713969e-3 |
GO:0046666 | retinal cell programmed cell death | 6.713969e-3 |
GO:0051493 | regulation of cytoskeleton organization | 6.716535e-3 |
GO:0000578 | embryonic axis specification | 6.743422e-3 |
GO:0006825 | copper ion transport | 6.779349e-3 |
GO:0072049 | comma-shaped body morphogenesis | 6.781793e-3 |
GO:0072050 | S-shaped body morphogenesis | 6.781793e-3 |
GO:0019934 | cGMP-mediated signaling | 6.842338e-3 |
GO:0045923 | positive regulation of fatty acid metabolic process | 6.864267e-3 |
GO:0045687 | positive regulation of glial cell differentiation | 7.017575e-3 |
GO:0021553 | olfactory nerve development | 7.172119e-3 |
GO:0009082 | branched chain family amino acid biosynthetic process | 7.172119e-3 |
GO:0060113 | inner ear receptor cell differentiation | 7.189730e-3 |
GO:0035802 | adrenal cortex formation | 7.343438e-3 |
GO:0014807 | regulation of somitogenesis | 7.343438e-3 |
GO:0003270 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation | 7.343438e-3 |
GO:0001835 | blastocyst hatching | 7.445661e-3 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 7.479034e-3 |
GO:0021586 | pons maturation | 7.479034e-3 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 7.538065e-3 |
GO:2000573 | positive regulation of DNA biosynthetic process | 7.538065e-3 |
GO:0002002 | regulation of angiotensin levels in blood | 7.538065e-3 |
GO:0035634 | response to stilbenoid | 7.719859e-3 |
GO:0009081 | branched chain family amino acid metabolic process | 7.719859e-3 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 7.807253e-3 |
GO:0019388 | galactose catabolic process | 7.807253e-3 |
GO:0006767 | water-soluble vitamin metabolic process | 7.854407e-3 |
GO:0007141 | male meiosis I | 7.863675e-3 |
GO:0032272 | negative regulation of protein polymerization | 7.926492e-3 |
GO:0006998 | nuclear envelope organization | 7.935514e-3 |
GO:0007528 | neuromuscular junction development | 8.022884e-3 |
GO:0010948 | negative regulation of cell cycle process | 8.029779e-3 |
GO:0042246 | tissue regeneration | 8.072050e-3 |
GO:0071287 | cellular response to manganese ion | 8.128609e-3 |
GO:0010159 | specification of organ position | 8.128609e-3 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 8.128609e-3 |
GO:0033692 | cellular polysaccharide biosynthetic process | 8.243098e-3 |
GO:0051336 | regulation of hydrolase activity | 8.259974e-3 |
GO:0021675 | nerve development | 8.272365e-3 |
GO:0035234 | germ cell programmed cell death | 8.294782e-3 |
GO:0051693 | actin filament capping | 8.341255e-3 |
GO:0001779 | natural killer cell differentiation | 8.731227e-3 |
GO:0060177 | regulation of angiotensin metabolic process | 8.756324e-3 |
GO:0007412 | axon target recognition | 8.783382e-3 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 8.783382e-3 |
GO:0009642 | response to light intensity | 8.935720e-3 |
GO:0006420 | arginyl-tRNA aminoacylation | 8.935720e-3 |
GO:0003094 | glomerular filtration | 8.935720e-3 |
GO:0008202 | steroid metabolic process | 8.941882e-3 |
GO:0051494 | negative regulation of cytoskeleton organization | 9.054403e-3 |
GO:0060561 | apoptosis involved in morphogenesis | 9.102984e-3 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 9.130288e-3 |
GO:0010897 | negative regulation of triglyceride catabolic process | 9.130288e-3 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 9.130288e-3 |
GO:0001843 | neural tube closure | 9.343322e-3 |
GO:0060052 | neurofilament cytoskeleton organization | 9.383746e-3 |
GO:0072006 | nephron development | 9.512496e-3 |
GO:0021604 | cranial nerve structural organization | 9.520634e-3 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 9.826077e-3 |
GO:0009110 | vitamin biosynthetic process | 9.851838e-3 |
GO:0071173 | spindle assembly checkpoint | 9.899266e-3 |
GO:2000080 | negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 9.962913e-3 |
GO:0060695 | negative regulation of cholesterol transporter activity | 9.962913e-3 |
GO:2000270 | negative regulation of fibroblast apoptosis | 9.962913e-3 |
GO:2000271 | positive regulation of fibroblast apoptosis | 9.962913e-3 |
GO:0021570 | rhombomere 4 development | 9.962913e-3 |
GO:0044345 | stromal-epithelial cell signaling involved in prostate gland development | 9.962913e-3 |
GO:0006097 | glyoxylate cycle | 9.962913e-3 |
GO:0015759 | beta-glucoside transport | 9.962913e-3 |
GO:0045956 | positive regulation of calcium ion-dependent exocytosis | 9.986258e-3 |
GO:0043366 | beta selection | 1.014484e-2 |
GO:0043407 | negative regulation of MAP kinase activity | 1.020440e-2 |
GO:0071104 | response to interleukin-9 | 1.020755e-2 |
GO:0061005 | cell differentiation involved in kidney development | 1.026778e-2 |
GO:0006939 | smooth muscle contraction | 1.036923e-2 |
GO:0015862 | uridine transport | 1.045796e-2 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 1.046894e-2 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.055350e-2 |
GO:0060376 | positive regulation of mast cell differentiation | 1.059490e-2 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 1.059490e-2 |
GO:0002125 | maternal aggressive behavior | 1.059490e-2 |
GO:0000238 | zygotene | 1.059490e-2 |
GO:0001821 | histamine secretion | 1.064240e-2 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 1.070264e-2 |
GO:0015693 | magnesium ion transport | 1.087498e-2 |
GO:0071529 | cementum mineralization | 1.105079e-2 |
GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 1.105079e-2 |
GO:0090084 | negative regulation of inclusion body assembly | 1.105079e-2 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 1.105079e-2 |
GO:0006867 | asparagine transport | 1.105079e-2 |
GO:0032796 | uropod organization | 1.105502e-2 |
GO:0022007 | convergent extension involved in neural plate elongation | 1.105502e-2 |
GO:0021796 | cerebral cortex regionalization | 1.105502e-2 |
GO:0046426 | negative regulation of JAK-STAT cascade | 1.111166e-2 |
GO:0048839 | inner ear development | 1.113012e-2 |
GO:0001975 | response to amphetamine | 1.123491e-2 |
GO:0007052 | mitotic spindle organization | 1.127824e-2 |
GO:0006626 | protein targeting to mitochondrion | 1.147932e-2 |
GO:0032876 | negative regulation of DNA endoreduplication | 1.160303e-2 |
GO:0072012 | glomerulus vasculature development | 1.186222e-2 |
GO:0060136 | embryonic process involved in female pregnancy | 1.188194e-2 |
GO:0032488 | Cdc42 protein signal transduction | 1.188194e-2 |
GO:0014029 | neural crest formation | 1.200976e-2 |
GO:0030307 | positive regulation of cell growth | 1.202070e-2 |
GO:0051586 | positive regulation of dopamine uptake | 1.236429e-2 |
GO:0032966 | negative regulation of collagen biosynthetic process | 1.236429e-2 |
GO:0019430 | removal of superoxide radicals | 1.242334e-2 |
GO:0015874 | norepinephrine transport | 1.242478e-2 |
GO:0045040 | protein import into mitochondrial outer membrane | 1.242478e-2 |
GO:0002444 | myeloid leukocyte mediated immunity | 1.265697e-2 |
GO:0042267 | natural killer cell mediated cytotoxicity | 1.270596e-2 |
GO:0000303 | response to superoxide | 1.284490e-2 |
GO:0035249 | synaptic transmission, glutamatergic | 1.284490e-2 |
GO:0060606 | tube closure | 1.286703e-2 |
GO:0008643 | carbohydrate transport | 1.288117e-2 |
GO:0006573 | valine metabolic process | 1.291459e-2 |
GO:0031577 | spindle checkpoint | 1.291459e-2 |
GO:0030832 | regulation of actin filament length | 1.293110e-2 |
GO:0007386 | compartment pattern specification | 1.312308e-2 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.313702e-2 |
GO:0003350 | pulmonary myocardium development | 1.324083e-2 |
GO:0071715 | icosanoid transport | 1.329348e-2 |
GO:0002026 | regulation of the force of heart contraction | 1.330101e-2 |
GO:0030030 | cell projection organization | 1.330582e-2 |
GO:0001895 | retina homeostasis | 1.334592e-2 |
GO:2000104 | negative regulation of DNA-dependent DNA replication | 1.334592e-2 |
GO:0046716 | muscle cell homeostasis | 1.335076e-2 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 1.335767e-2 |
GO:0051639 | actin filament network formation | 1.335767e-2 |
GO:0006650 | glycerophospholipid metabolic process | 1.338327e-2 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 1.347906e-2 |
GO:0007403 | glial cell fate determination | 1.348348e-2 |
GO:0032000 | positive regulation of fatty acid beta-oxidation | 1.354637e-2 |
GO:2000974 | negative regulation of pro-B cell differentiation | 1.397369e-2 |
GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 1.397369e-2 |
GO:0006868 | glutamine transport | 1.397369e-2 |
GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 1.397369e-2 |
GO:0033124 | regulation of GTP catabolic process | 1.403161e-2 |
GO:0014066 | regulation of phosphatidylinositol 3-kinase cascade | 1.404597e-2 |
GO:0072144 | glomerular mesangial cell development | 1.422429e-2 |
GO:0045916 | negative regulation of complement activation | 1.422429e-2 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.444165e-2 |
GO:0034959 | endothelin maturation | 1.445260e-2 |
GO:0010816 | calcitonin catabolic process | 1.445260e-2 |
GO:0010814 | substance P catabolic process | 1.445260e-2 |
GO:0006011 | UDP-glucose metabolic process | 1.445260e-2 |
GO:0030431 | sleep | 1.448750e-2 |
GO:0050711 | negative regulation of interleukin-1 secretion | 1.472269e-2 |
GO:0032674 | regulation of interleukin-5 production | 1.502956e-2 |
GO:0060911 | cardiac cell fate commitment | 1.504993e-2 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 1.505197e-2 |
GO:0048227 | plasma membrane to endosome transport | 1.505197e-2 |
GO:2000469 | negative regulation of peroxidase activity | 1.505197e-2 |
GO:2000429 | negative regulation of neutrophil aggregation | 1.505197e-2 |
GO:0021528 | commissural neuron differentiation in spinal cord | 1.505197e-2 |
GO:0034120 | positive regulation of erythrocyte aggregation | 1.505197e-2 |
GO:0035726 | common myeloid progenitor cell proliferation | 1.505197e-2 |
GO:0043252 | sodium-independent organic anion transport | 1.505197e-2 |
GO:0006556 | S-adenosylmethionine biosynthetic process | 1.524089e-2 |
GO:0032108 | negative regulation of response to nutrient levels | 1.540094e-2 |
GO:0032479 | regulation of type I interferon production | 1.552781e-2 |
GO:0015718 | monocarboxylic acid transport | 1.557149e-2 |
GO:0051387 | negative regulation of nerve growth factor receptor signaling pathway | 1.568112e-2 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 1.568112e-2 |
GO:0032535 | regulation of cellular component size | 1.580308e-2 |
GO:0009083 | branched chain family amino acid catabolic process | 1.584161e-2 |
GO:0006306 | DNA methylation | 1.596443e-2 |
GO:0048103 | somatic stem cell division | 1.604358e-2 |
GO:0050925 | negative regulation of negative chemotaxis | 1.605158e-2 |